<?xml version="1.0" encoding="UTF-8"?>
<p>Recent scholarship has examined the ethics of including pregnant women in clinical research on therapeutics and vaccines. The Second Wave Project was the largest initiative to enumerate the harms of exclusion: limited data on medication pharmacokinetics and safety during pregnancy for both mother and fetus, a reluctance to treat maternal illness during pregnancy, and a lack of access to trials with the prospect of direct benefit to the mother and/or fetus
 <xref rid="eahr500060-bib-0024" ref-type="ref">
  <sup>24</sup>
 </xref> (the latter being a violation of the principles of justice and equity). This stance also violates the autonomy of pregnant women, since it implicitly denies them an ability to make reasoned choices for themselves and their future children about whether to accept or refuse clinical trial participation based on their own judgment—judgment that, after the child's birth, they would nearly all have the power to exercise.
 <xref rid="eahr500060-bib-0025" ref-type="ref">
  <sup>25</sup>
 </xref> The Second Wave Project highlighted pervasive assumptions that exclusion from research is a safer default position than inclusion and pointed out the glaring flaw in this assumption: that, in many contexts, “our evidence base for current treatments is so weak that standard practice is itself more like experiment than treatment.”
 <xref rid="eahr500060-bib-0026" ref-type="ref">
  <sup>26</sup>
 </xref> Exclusion carries its own practical risks.
</p>
